Global Burden of Prostate Cancer Accelerates Demand Radioligand Therapy

Radioligand Therapy Market

The most typical cancer in American males, aside from skin cancer, is prostate cancer. According to projections made by the American Cancer Society, 34,500 men would die from prostate cancer in the U.S. in 2022. Older males and non-Hispanic men have a higher risk of developing prostate cancer. Males 65 or older account for around 6 out of 10 occurrences, … Continua a leggere